Literature DB >> 25755385

Nutritional status and liver transplantation.

Manuela Merli1, Michela Giusto1, Valerio Giannelli1, Cristina Lucidi1, Oliviero Riggio1.   

Abstract

Chronic liver disease has a profound effect on nutritional status and undernourishment is almost universally present in patients with end-stage liver disease undergoing liver transplantation. In the last decades, due to epidemiological changes, a trend showing an increase in patients with end-stage liver disease and associated obesity has also been reported in developed countries. Nutrition abnormalities may influence the outcome after transplantation therefore, the importance to carefully assess the nutritional status in the work-up of patients candidates for liver transplantation is widely accepted. More attention has been given to malnourished patients as they represent the greater number. The subjective global nutritional assessment and anthropometric measurements are recognized in current guidelines to be adequate in identifying those patients at risk of malnutrition. Cirrhotic patients with a depletion in lean body mass and fat deposits have an increased surgical risk and malnutrition may impact on morbidity, mortality and costs in the post-transplantation setting. For this reason an adequate calorie and protein intake should always be ensured to malnourished cirrhotic patient either through the diet, or using oral nutritional supplements or by enteral or parenteral nutrition although studies supporting the efficacy of nutritional supplementation in improving the clinical outcomes after transplantation are still scarce. When liver function is restored, an amelioration in the nutritional status is expected. After liver transplantation in fact dietary intake rapidly normalizes and fat mass is progressively regained while the recovery of muscle mass can be slower. In some patients unregulated weight gain may lead to over-nutrition and may favor metabolic disorders (hypertension, hyperglycemia, hyperlipidemia). This condition, defined as 'metabolic syndrome', may play a negative role on the overall survival of liver transplant patients. In this report we review data on nutrition and liver transplantation.

Entities:  

Keywords:  BCAA, branched chain amino acids; BMI, body mass index; Body weight; LT, liver transplantation; MELD, model for end-stage liver disease; SGA, subjective global assessment for nutrition; cirrhosis; end stage liver disease; malnutrition; nutritional assessment; nutritional support or nutritional therapy; obesity; outcomes

Year:  2012        PMID: 25755385      PMCID: PMC3940406          DOI: 10.1016/S0973-6883(11)60237-5

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  70 in total

1.  Influence of obesity with concurrent diseases on liver transplant survival.

Authors:  James D Perkins
Journal:  Liver Transpl       Date:  2007-06       Impact factor: 5.799

Review 2.  Liver transplantation: the current situation.

Authors:  Rene Adam; Emir Hoti
Journal:  Semin Liver Dis       Date:  2009-02-23       Impact factor: 6.115

3.  Morbid obesity and gross malnutrition are both poor predictors of outcomes after liver transplantation: what can we do about it?

Authors:  Paul J Thuluvath
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

4.  ESPEN Guidelines on Parenteral Nutrition: hepatology.

Authors:  Mathias Plauth; Eduard Cabré; Bernard Campillo; Jens Kondrup; Giulio Marchesini; Tatjana Schütz; Alan Shenkin; Julia Wendon
Journal:  Clin Nutr       Date:  2009-06-11       Impact factor: 7.324

5.  Factors associated with nutritional status in liver transplant patients who survived the first year after transplantation.

Authors:  Luciana de Carvalho; Edison Roberto Parise; Didier Samuel
Journal:  J Gastroenterol Hepatol       Date:  2009-11-19       Impact factor: 4.029

6.  Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.

Authors:  Mário Reis Alvares-da-Silva; Themis Reverbel da Silveira
Journal:  Nutrition       Date:  2005-02       Impact factor: 4.008

7.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

8.  Impact of nutritional status on outcomes after liver transplantation.

Authors:  F Figueiredo; E R Dickson; T Pasha; P Kasparova; T Therneau; M Malinchoc; S DiCecco; N Francisco-Ziller; M Charlton
Journal:  Transplantation       Date:  2000-11-15       Impact factor: 4.939

9.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

Review 10.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

View more
  9 in total

Review 1.  Changes in nutritional status after liver transplantation.

Authors:  Michela Giusto; Barbara Lattanzi; Vincenza Di Gregorio; Valerio Giannelli; Cristina Lucidi; Manuela Merli
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.

Authors:  Cynthia Tsien; Ari Garber; Arvind Narayanan; Shetal N Shah; David Barnes; Bijan Eghtesad; John Fung; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

Review 3.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

Review 4.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

Review 5.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

6.  Utility of the simplified measurements of muscle mass in patients with gastrointestinal and chronic liver diseases.

Authors:  Hitomi Takada; Fumitake Amemiya; Tomoki Yasumura; Hiroki Yoda; Tetsuya Okuwaki; Keisuke Tanaka; Makoto Kadokura; Nobuyuki Enomoto
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

7.  Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation.

Authors:  Mei-Yun Wu; Sheng-Chih Kuo; Su-Fen Chuang; Cheng-Hsi Yeh; Shih-Min Yin; Wei-Feng Li; Hung-Jen Wang; Chao-Long Chen; Chih-Chi Wang; Chih-Che Lin
Journal:  Ann Med Surg (Lond)       Date:  2021-02-18

Review 8.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

9.  The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study.

Authors:  Barbara Lattanzi; Michela Giusto; Carlina Albanese; Gianluca Mennini; Daria D'Ambrosio; Alessio Farcomeni; Stefano Ginanni Corradini; Massimo Rossi; Manuela Merli
Journal:  Nutrients       Date:  2019-09-19       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.